MARKET

RASP

RASP

Actavia Life Sciences
EXMKT
0.0004
NaN%
Opening 09:30 02/09 EST
OPEN
--
PREV CLOSE
0.0004
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0004
52 WEEK LOW
0.0004
MARKET CAP
308.72K
P/E (TTM)
-0.8000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RASP last week (0908-0912)?
Weekly Report · 09/15/2025 09:48
Weekly Report: what happened at RASP last week (0901-0905)?
Weekly Report · 09/08/2025 09:49
Weekly Report: what happened at RASP last week (0825-0829)?
Weekly Report · 09/01/2025 09:47
Weekly Report: what happened at RASP last week (0818-0822)?
Weekly Report · 08/25/2025 09:50
Weekly Report: what happened at RASP last week (0811-0815)?
Weekly Report · 08/18/2025 09:48
Weekly Report: what happened at RASP last week (0804-0808)?
Weekly Report · 08/11/2025 09:50
Weekly Report: what happened at RASP last week (0728-0801)?
Weekly Report · 08/04/2025 09:52
Weekly Report: what happened at RASP last week (0721-0725)?
Weekly Report · 07/28/2025 09:52
More
About RASP
Actavia Life Sciences, Inc. is a leukemia-focused biotechnology company. The Company is engaged in developing therapeutics to address the unmet need that exists for acute myeloid leukemia (AML), and other forms of leukemia and lymphoma. AML is generally a disease of older adults. It develops small molecule drug candidates targeting the LSD1 gene, which controls pathways underlying the etiology of AML subtypes. Its RASP-201 is a novel, orally dosed, selective reversible inhibitor of lysine specific demethylase (LSD1), a pathway that blocks differentiation and confers a poor prognosis to AML. RASP-201 when dosed orally shows in vivo therapeutic utility in murine (mouse) models of AML. Its primary indication is AML which may be fatal within weeks to months.

Webull offers Actavia Life Sciences Inc stock information, including EXMKT: RASP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RASP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RASP stock methods without spending real money on the virtual paper trading platform.